Viewing Study NCT05202405


Ignite Creation Date: 2025-12-25 @ 3:16 AM
Ignite Modification Date: 2025-12-26 @ 1:55 AM
Study NCT ID: NCT05202405
Status: COMPLETED
Last Update Posted: 2022-07-20
First Post: 2022-01-09
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Evaluate the Safety and Pharmacokinetics of AD-221 Compared to Coadministration of AD-221A and AD-221B
Sponsor: Addpharma Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-01-05
Start Date Type: ACTUAL
Primary Completion Date: 2022-03-04
Primary Completion Date Type: ACTUAL
Completion Date: 2022-03-04
Completion Date Type: ACTUAL
First Submit Date: 2022-01-09
First Submit QC Date: None
Study First Post Date: 2022-01-21
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-07-19
Last Update Post Date: 2022-07-20
Last Update Post Date Type: ACTUAL